{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T08:24:33Z","timestamp":1793953473893,"version":"4.8.0"},"reference-count":155,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.pnpbp.2026.111660","type":"journal-article","created":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T17:06:09Z","timestamp":1772816769000},"page":"111660","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications"],"prefix":"10.1016","volume":"146","author":[{"given":"Urvashi","family":"Soni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohini","family":"Pujari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0005","article-title":"APOLLOE4 phase 3 study of oral ALZ-801\/valiltramiprosate in APOE \u03b54\/\u03b54 homozygotes with early Alzheimer\u2019s disease: trial design and baseline characteristics","volume":"10","author":"Abushakra","year":"2024","journal-title":"Alzheimers Dement (N Y)"},{"issue":"22","key":"10.1016\/j.pnpbp.2026.111660_bb0010","doi-asserted-by":"crossref","first-page":"12583","DOI":"10.1021\/acsomega.0c01592","article-title":"Nanocarriers as potential drug delivery candidates for overcoming the blood\u2013brain barrier: challenges and possibilities","volume":"5","author":"Ahlawat","year":"2020","journal-title":"ACS Omega"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0015","article-title":"A common molecular and cellular pathway in developing Alzheimer and cancer","volume":"37","author":"Ali","year":"2024","journal-title":"Biochem. Biophys. Rep."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111660_bb0020","doi-asserted-by":"crossref","DOI":"10.3390\/jpm15090437","article-title":"Anti-amyloid monoclonal antibodies for Alzheimer\u2019s disease: evidence, ARIA risk, and precision patient selection","volume":"15","author":"Alkhalifa","year":"2025","journal-title":"J Pers Med"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0025","article-title":"The pathogenesis of Alzheimer\u2019s disease: a reevaluation of the \u201camyloid cascade hypothesis\u201d","volume":"2011","author":"Armstrong","year":"2011","journal-title":"Int. J. Alzheimers Dis."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0030","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3389\/fnmol.2017.00088","article-title":"The role of astrocytes in neuroprotection after brain stroke: potential in cell therapy","volume":"10","author":"Becerra-Calixto","year":"2017","journal-title":"Front Mol Neurosci"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0035","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0040","article-title":"Role of Synbiotics in neurodegenerative diseases","volume":"97","author":"Bhatt","year":"2024","journal-title":"Synbiotics in Human Health: Biology to Drug Deliv."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0045","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.3389\/fnagi.2019.00369","article-title":"Lifestyle modifications and nutritional interventions in aging-associated cognitive decline and Alzheimer\u2019s disease [review]","volume":"Volume 11","author":"Bhatti","year":"2020","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0050","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.mito.2021.02.007","article-title":"Protective effects of a mitochondria-targeted small peptide SS31 against hyperglycemia-induced mitochondrial abnormalities in the liver tissues of diabetic mice, tallyho\/JngJ mice","volume":"58","author":"Bhatti","year":"2021","journal-title":"Mitochondrion"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0055","doi-asserted-by":"crossref","first-page":"589","DOI":"10.3233\/JPD-171191","article-title":"C-Abl and Parkinson\u2019s disease: mechanisms and therapeutic potential","volume":"7","author":"Brahmachari","year":"2017","journal-title":"J. Parkinsons Dis."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105509","article-title":"Oxidative stress: A target to treat Alzheimer\u2019s disease and stroke","volume":"165","author":"Briyal","year":"2023","journal-title":"Neurochem. Int."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111660_bb0065","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1474-4422(21)00043-0","article-title":"Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer\u2019s disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial","volume":"20","author":"Burns","year":"2021","journal-title":"Lancet Neurol."},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111660_bb0070","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1089\/ars.2012.5027","article-title":"Amyloid \u03b2-peptide (1-42)-induced oxidative stress in Alzheimer disease: importance in disease pathogenesis and progression","volume":"19","author":"Butterfield","year":"2013","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0075","article-title":"Microglia in the Neuroinflammatory pathogenesis of Alzheimer's disease and related therapeutic targets","volume":"13","author":"Cai","year":"2022","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111660_bb0080","doi-asserted-by":"crossref","DOI":"10.3390\/cells9112513","article-title":"Therapeutic strategies to target calcium dysregulation in Alzheimer\u2019s disease","volume":"9","author":"Calvo-Rodriguez","year":"2020","journal-title":"Cells"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111660_bb0085","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1080\/1028415X.2017.1321813","article-title":"Omega-3 fatty acids\u2019 supplementation in Alzheimer\u2019s disease: A systematic review","volume":"21","author":"Canhada","year":"2018","journal-title":"Nutr. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0090","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1258640","article-title":"Blood-brain barrier dysfunction and Alzheimer's disease: associations, pathogenic mechanisms, and therapeutic potential","volume":"15","author":"Chen","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12987-024-00557-1","article-title":"Cellular and molecular mechanisms of the blood-brain barrier dysfunction in neurodegenerative diseases","volume":"21","author":"Chen","year":"2024","journal-title":"Fluids Barriers CNS"},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111660_bb0100","doi-asserted-by":"crossref","DOI":"10.3390\/molecules29071478","article-title":"Neuroinflammation of microglial regulation in Alzheimer's disease: therapeutic approaches","volume":"29","author":"Chen","year":"2024","journal-title":"Molecules"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111660_bb0105","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10102434","article-title":"Role of Sirtuins in physiology and diseases of the central nervous system","volume":"10","author":"Chojdak-\u0141ukasiewicz","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0110","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/bs.apha.2014.06.009","article-title":"P-glycoprotein trafficking as a therapeutic target to optimize CNS drug delivery","volume":"71","author":"Davis","year":"2014","journal-title":"Adv. Pharmacol."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0115","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1111\/jnc.12675","article-title":"Insights into the physiological function of the \u03b2-amyloid precursor protein: beyond Alzheimer\u2019s disease","volume":"129","author":"Dawkins","year":"2014","journal-title":"J. Neurochem."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0120","doi-asserted-by":"crossref","DOI":"10.3390\/biom13030549","article-title":"The role of the transcription factor Nrf2 in Alzheimer\u2019s disease: therapeutic opportunities","volume":"13","author":"De Plano","year":"2023","journal-title":"Biomolecules"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1021\/acs.jmedchem.0c00931","article-title":"Glycogen synthase kinase 3\u03b2: A new gold rush in anti-Alzheimer's disease multitarget drug discovery?","volume":"64","author":"De Simone","year":"2021","journal-title":"J. Med. Chem."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111660_bb0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1080\/14728222.2018.1486823","article-title":"Triggering receptor expressed on myeloid cells 2 (TREM2): a potential therapeutic target for Alzheimer disease?","volume":"22","author":"Deming","year":"2018","journal-title":"Expert Opin. Ther. Targets"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0135","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.neurobiolaging.2013.08.031","article-title":"\u0392-Amyloid impairs the regulation of N-methyl-D-aspartate receptors by glycogen synthase kinase 3","volume":"35","author":"Deng","year":"2014","journal-title":"Neurobiol. Aging"},{"issue":"17","key":"10.1016\/j.pnpbp.2026.111660_bb0140","doi-asserted-by":"crossref","DOI":"10.3390\/cells11172728","article-title":"Role of microglia and astrocytes in Alzheimer\u2019s disease: from Neuroinflammation to ca(2+) homeostasis dysregulation","volume":"11","author":"Di Benedetto","year":"2022","journal-title":"Cells"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0145","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1742-2094-11-48","article-title":"Microglia receptors and their implications in the response to amyloid \u03b2 for Alzheimer\u2019s disease pathogenesis","volume":"11","author":"Doens","year":"2014","journal-title":"J. Neuroinflammation"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0150","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13195-023-01169-x","article-title":"Masitinib for mild-to-moderate Alzheimer\u2019s disease: results from a randomized, placebo-controlled, phase 3, clinical trial","volume":"15","author":"Dubois","year":"2023","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0155","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13195-019-0520-1","article-title":"Further analyses of the safety of verubecestat in the phase 3 EPOCH trial of mild-to-moderate Alzheimer\u2019s disease","volume":"11","author":"Egan","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0160","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.7150\/thno.99908","article-title":"Neurotrophic factor-\u03b11\/carboxypeptidase E controls progression and reversal of Alzheimer\u2019s disease pathogenesis in mice","volume":"15","author":"Fan","year":"2025","journal-title":"Theranostics"},{"issue":"23","key":"10.1016\/j.pnpbp.2026.111660_bb0165","doi-asserted-by":"crossref","first-page":"15857","DOI":"10.1074\/jbc.M808986200","article-title":"Wnt-5a\/JNK signaling promotes the clustering of PSD-95 in hippocampal neurons","volume":"284","author":"Far\u00edas","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0170","first-page":"Cd002854","article-title":"Vitamin E for Alzheimer's dementia and mild cognitive impairment","volume":"4","author":"Farina","year":"2017","journal-title":"Cochrane Database Syst. Rev."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0175","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25030762","article-title":"Therapeutic potential of flavonoids in pain and inflammation: mechanisms of action, pre-clinical and clinical data, and pharmaceutical development","volume":"25","author":"Ferraz","year":"2020","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bib771","article-title":"CoQ10 and Mitochondrial Dysfunction in Alzheimer's Disease","volume":"13","author":"Fi\u0161ar","year":"2024","journal-title":"Antioxidants (Basel)"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0180","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/s41583-021-00533-w","article-title":"The probabilistic model of Alzheimer disease: the amyloid hypothesis revised","volume":"23","author":"Frisoni","year":"2022","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0185","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtemb.2025.127612","article-title":"Assessment of neuroprotective potential of Cuscuta reflexa in aluminium chloride-induced experimental model of Alzheimer's disease: in vitro and in vivo studies","volume":"88","author":"Gangarde","year":"2025","journal-title":"J. Trace Elem. Med. Biol."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0190","doi-asserted-by":"crossref","DOI":"10.3390\/cimb47060417","article-title":"Neuroinflammation: mechanisms, dual roles, and therapeutic strategies in neurological disorders","volume":"47","author":"Garc\u00eda-Dom\u00ednguez","year":"2025","journal-title":"Curr. Issues Mol. Biol."},{"issue":"23","key":"10.1016\/j.pnpbp.2026.111660_bb0195","doi-asserted-by":"crossref","first-page":"2321","DOI":"10.2174\/092986708785909111","article-title":"Hyperphosphorylation of microtubule-associated protein tau: a promising therapeutic target for Alzheimer disease","volume":"15","author":"Gong","year":"2008","journal-title":"Curr. Med. Chem."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0200","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8050651","article-title":"Vascular dysfunction in Alzheimer\u2019s disease: A prelude to the pathological process or a consequence of it?","volume":"8","author":"Govindpani","year":"2019","journal-title":"J. Clin. Med."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0205","doi-asserted-by":"crossref","first-page":"237","DOI":"10.4103\/1673-5374.346540","article-title":"C-Abl kinase at the crossroads of healthy synaptic remodeling and synaptic dysfunction in neurodegenerative diseases","volume":"18","author":"Guti\u00e9rrez","year":"2023","journal-title":"Neural Regen. Res."},{"issue":"13","key":"10.1016\/j.pnpbp.2026.111660_bb0210","doi-asserted-by":"crossref","first-page":"9063","DOI":"10.1021\/acs.jmedchem.2c00313","article-title":"SAGE-718: A first-in-class N-methyl\u2011d-aspartate receptor positive allosteric modulator for the potential treatment of cognitive impairment","volume":"65","author":"Hill","year":"2022","journal-title":"J. Med. Chem."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0215","doi-asserted-by":"crossref","DOI":"10.1002\/prp2.70131","article-title":"Multi-target drug Design in Alzheimer\u2019s disease treatment: emerging technologies, advantages, challenges, and limitations","volume":"13","author":"Hossain","year":"2025","journal-title":"Pharmacol. Res. Perspect."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111660_bb0220","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1016\/j.jmb.2019.01.018","article-title":"Metal toxicity links to Alzheimer\u2019s disease and Neuroinflammation","volume":"431","author":"Huat","year":"2019","journal-title":"J. Mol. Biol."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0225","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s12276-022-00754-8","article-title":"\u0393-Secretase in Alzheimer\u2019s disease","volume":"54","author":"Hur","year":"2022","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0230","article-title":"Are NSAIDs useful to treat Alzheimer\u2019s disease or mild cognitive impairment?","volume":"2","author":"Imbimbo","year":"2010","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0235","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.neurobiolaging.2021.07.014","article-title":"Emerging roles of oxidative stress in brain aging and Alzheimer\u2019s disease","volume":"107","author":"Ionescu-Tucker","year":"2021","journal-title":"Neurobiol. Aging"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111660_bb0240","doi-asserted-by":"crossref","first-page":"656","DOI":"10.2174\/156720510793611592","article-title":"Tau in Alzheimer disease and related tauopathies","volume":"7","author":"Iqbal","year":"2010","journal-title":"Curr. Alzheimer Res."},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111660_bb0245","doi-asserted-by":"crossref","first-page":"14579","DOI":"10.3390\/ijms131114579","article-title":"Glatiramer acetate in treatment of multiple sclerosis: A toolbox of random co-polymers for targeting inflammatory mechanisms of both the innate and adaptive immune system?","volume":"13","author":"Jalilian","year":"2012","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111660_bb0250","doi-asserted-by":"crossref","first-page":"5099","DOI":"10.1016\/j.apsb.2025.08.015","article-title":"New insights into translational research in Alzheimer's disease guided by artificial intelligence, computational and systems biology","volume":"15","author":"Jiang","year":"2025","journal-title":"Acta Pharm. Sin. B"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0255","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.3233\/JAD-161118","article-title":"Therapeutics of neurotransmitters in Alzheimer\u2019s disease","volume":"57","author":"Kandimalla","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111660_bb0260","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1182\/blood-2007-03-080689","article-title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome-positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","volume":"110","author":"Kantarjian","year":"2007","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0265","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s44337-025-00455-x","article-title":"Diagnostic and therapeutic potential of microRNAs and long noncoding RNAs in the molecular mechanisms of Alzheimer disease","volume":"2","author":"Kashif","year":"2025","journal-title":"Discov. Med."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0270","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.tins.2017.01.002","article-title":"Mitophagy and Alzheimer\u2019s disease: cellular and molecular mechanisms","volume":"40","author":"Kerr","year":"2017","journal-title":"Trends Neurosci."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0275","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.bbr.2008.09.040","article-title":"Minocycline and neurodegenerative diseases","volume":"196","author":"Kim","year":"2009","journal-title":"Behav. Brain Res."},{"issue":"1\u20132","key":"10.1016\/j.pnpbp.2026.111660_bb0280","first-page":"12","article-title":"A protective role of nuclear factor-erythroid 2-related factor-2 (Nrf2) in inflammatory disorders","volume":"690","author":"Kim","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101618","article-title":"Reducing neuroinflammation via therapeutic compounds and lifestyle to prevent or delay progression of Parkinson\u2019s disease","volume":"78","author":"Kip","year":"2022","journal-title":"Ageing Res. Rev."},{"issue":"15","key":"10.1016\/j.pnpbp.2026.111660_bb0290","doi-asserted-by":"crossref","DOI":"10.3390\/nu16152476","article-title":"Nebulized glutathione as a key antioxidant for the treatment of oxidative stress in neurodegenerative conditions","volume":"16","author":"Lana","year":"2024","journal-title":"Nutrients"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111660_bb0295","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s40263-019-00658-8","article-title":"Targeting mitochondria in Alzheimer disease: rationale and perspectives","volume":"33","author":"Lanzillotta","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0300","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1180987","article-title":"C-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer\u2019s disease","volume":"15","author":"Le\u00f3n","year":"2023","journal-title":"Front. Aging Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0305","doi-asserted-by":"crossref","first-page":"949","DOI":"10.14336\/AD.2019.0120","article-title":"Metformin alters locomotor and cognitive function and brain metabolism in Normoglycemic mice","volume":"10","author":"Li","year":"2019","journal-title":"Aging Dis."},{"issue":"16","key":"10.1016\/j.pnpbp.2026.111660_bb0310","article-title":"Development of novel therapeutics targeting the blood-brain barrier: from barrier to carrier","volume":"8","author":"Li","year":"2021","journal-title":"Adv Sci (Weinh)"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0315","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/s41398-024-03075-8","article-title":"MicroRNAs: pioneering regulators in Alzheimer's disease pathogenesis, diagnosis, and therapy","volume":"14","author":"Li","year":"2024","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0320","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2024.177099","article-title":"Ellagic acid(EA) ameliorates Alzheimer's disease by reducing a\u03b2 levels, oxidative stress and attenuating inflammation","volume":"986","author":"Li","year":"2025","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0325","first-page":"46","article-title":"GSK-3\u03b2, a pivotal kinase in Alzheimer disease","volume":"7","author":"Llorens-Mart\u00edn","year":"2014","journal-title":"Front Mol Neurosci"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0330","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: an update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0335","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062897","article-title":"Physical exercise and Alzheimer\u2019s disease: effects on pathophysiological molecular pathways of the disease","volume":"22","author":"L\u00f3pez-Ortiz","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"16","key":"10.1016\/j.pnpbp.2026.111660_bb0340","doi-asserted-by":"crossref","DOI":"10.3390\/nu14163367","article-title":"Nootropics as cognitive enhancers: types, dosage and side effects of smart drugs","volume":"14","author":"Mal\u00edk","year":"2022","journal-title":"Nutrients"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0345","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13195-016-0221-y","article-title":"Selective suppression of the \u03b1 isoform of p38 MAPK rescues late-stage tau pathology","volume":"8","author":"Maphis","year":"2016","journal-title":"Alzheimer\u2019s Res. Ther."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111660_bb0350","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s40263-019-00657-9","article-title":"Emerging developments in targeting Proteotoxicity in neurodegenerative diseases","volume":"33","author":"McAlary","year":"2019","journal-title":"CNS Drugs"},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0355","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1111\/j.1755-5949.2010.00177.x","article-title":"The role of tau in Alzheimer\u2019s disease and related disorders","volume":"17","author":"Medeiros","year":"2011","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0360","doi-asserted-by":"crossref","DOI":"10.3389\/fnsyn.2023.1129036","article-title":"Alzheimer's disease as a synaptopathy: evidence for dysfunction of synapses during disease progression","volume":"15","author":"Meftah","year":"2023","journal-title":"Front Synaptic Neurosci"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0365","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1186\/s13195-019-0553-5","article-title":"Characterization of the selective in vitro and in vivo binding properties of crenezumab to oligomeric a\u03b2","volume":"11","author":"Meilandt","year":"2019","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0370","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2023.1201982","article-title":"Microglia in Alzheimer's disease: pathogenesis, mechanisms, and therapeutic potentials","volume":"15","author":"Miao","year":"2023","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0375","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.570045","article-title":"Tau protein and its role in blood-brain barrier dysfunction","volume":"13","author":"Michalicova","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0380","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1038\/srep01302","article-title":"Bapineuzumab captures the N-terminus of the Alzheimer\u2019s disease amyloid-beta peptide in a helical conformation","volume":"3","author":"Miles","year":"2013","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010340","article-title":"Therapeutic effects of green tea polyphenol (\u2212)-Epigallocatechin-3-Gallate (EGCG) in relation to molecular pathways controlling inflammation, oxidative stress, and apoptosis","volume":"24","author":"Mokra","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0390","doi-asserted-by":"crossref","first-page":"1812","DOI":"10.3390\/ph3061812","article-title":"Non-steroidal anti-inflammatory drugs in Alzheimer\u2019s disease and Parkinson\u2019s disease: reconsidering the role of Neuroinflammation","volume":"3","author":"Moore","year":"2010","journal-title":"Pharmaceuticals (Basel)"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0395","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.freeradbiomed.2021.07.013","article-title":"Defective mitophagy and synaptic degeneration in Alzheimer\u2019s disease: focus on aging, mitochondria and synapse","volume":"172","author":"Morton","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"16","key":"10.1016\/j.pnpbp.2026.111660_bb0400","doi-asserted-by":"crossref","DOI":"10.3390\/cells12162041","article-title":"The role of c-Abl tyrosine kinase in brain and its pathologies","volume":"12","author":"Motaln","year":"2023","journal-title":"Cells"},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0405","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.bbadis.2012.01.009","article-title":"Oxidative stress increases BACE1 protein levels through activation of the PKR-eIF2\u03b1 pathway","volume":"1822","author":"Mouton-Liger","year":"2012","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0410","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/726954","article-title":"Metal dyshomeostasis and inflammation in Alzheimer's and Parkinson's diseases: possible impact of environmental exposures","volume":"2013","author":"Myhre","year":"2013","journal-title":"Oxid. Med. Cell. Longev."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0415","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/NEN.0b013e3181919a48","article-title":"Neuropathology and cognitive impairment in Alzheimer disease: a complex but coherent relationship","volume":"68","author":"Nelson","year":"2009","journal-title":"J. Neuropathol. Exp. Neurol."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0420","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1038\/aps.2011.14","article-title":"Small molecule inhibitors of amyloid \u03b2 peptide aggregation as a potential therapeutic strategy for Alzheimer\u2019s disease","volume":"32","author":"Nie","year":"2011","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0425","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev-neuro-061010-113613","article-title":"Amyloid precursor protein processing and Alzheimer\u2019s disease","volume":"34","author":"O\u2019Brien","year":"2011","journal-title":"Annu. Rev. Neurosci."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0430","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2174\/156720512801322564","article-title":"N-methyl D-aspartate (NMDA) receptor antagonists and memantine treatment for Alzheimer\u2019s disease, vascular dementia and Parkinson\u2019s disease","volume":"9","author":"Olivares","year":"2012","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0435","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/j.ccr.2011.11.004","article-title":"Nilotinib and MEK inhibitors induce synthetic lethality through paradoxical activation of RAF in drug-resistant chronic myeloid leukemia","volume":"20","author":"Packer","year":"2011","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0440","doi-asserted-by":"crossref","first-page":"503","DOI":"10.3233\/JPD-160867","article-title":"Nilotinib effects in Parkinson\u2019s disease and dementia with Lewy bodies","volume":"6","author":"Pagan","year":"2016","journal-title":"J. Parkinsons Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0445","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1001\/jamaneurol.2019.4200","article-title":"Nilotinib effects on safety, tolerability, and potential biomarkers in Parkinson disease: A phase 2 randomized clinical trial","volume":"77","author":"Pagan","year":"2020","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0450","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3389\/fncel.2019.00227","article-title":"Wnt signaling deregulation in the aging and Alzheimer\u2019s brain","volume":"13","author":"Palomer","year":"2019","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0455","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.mito.2021.03.008","article-title":"Endoplasmic reticulum & mitochondrial calcium homeostasis: the interplay with viruses","volume":"58","author":"Panda","year":"2021","journal-title":"Mitochondrion"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0460","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12035-021-02555-y","article-title":"Gene therapy approach with an emphasis on growth factors: theoretical and clinical outcomes in neurodegenerative diseases","volume":"59","author":"Parambi","year":"2022","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111660_bb0465","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022349","article-title":"Ensemble place codes in hippocampus: CA1, CA3, and dentate gyrus place cells have multiple place fields in large environments","volume":"6","author":"Park","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0470","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2022.969547","article-title":"Amyloid precursor protein (APP) and amyloid \u03b2 (a\u03b2) interact with cell adhesion molecules: implications in Alzheimer\u2019s disease and normal physiology","volume":"10","author":"Pfundstein","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0475","article-title":"Aging and Alzheimer\u2019s: the critical role of mitochondrial dysfunction and synaptic alterations","volume":"17","author":"Pinky","year":"2025","journal-title":"Front. Synaptic Neurosci."},{"issue":"5\u20138","key":"10.1016\/j.pnpbp.2026.111660_bb0480","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s13195-014-0075-0","article-title":"\u0392-Site amyloid precursor protein-cleaving enzyme 1(BACE1) inhibitor treatment induces A\u03b25-X peptides through alternative amyloid precursor protein cleavage","volume":"6","author":"Portelius","year":"2014","journal-title":"Alzheimer\u2019s Res. Ther."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0485","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2020.101191","article-title":"Defective mitophagy in Alzheimer\u2019s disease","volume":"64","author":"Pradeepkiran","year":"2020","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0490","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/413808","article-title":"Amyloidosis in Alzheimer's disease: the toxicity of amyloid Beta (A \u03b2), mechanisms of its accumulation and implications of medicinal plants for therapy","volume":"2013","author":"Prasansuklab","year":"2013","journal-title":"Evid. Based Complement. Alternat. Med."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0495","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.cmet.2012.04.003","article-title":"SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function","volume":"15","author":"Price","year":"2012","journal-title":"Cell Metab."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0500","doi-asserted-by":"crossref","first-page":"4508","DOI":"10.1021\/acsomega.2c06939","article-title":"Role of metal cations of copper, Iron, and aluminum and multifunctional ligands in Alzheimer's disease: experimental and computational insights","volume":"8","author":"Puentes-D\u00edaz","year":"2023","journal-title":"ACS Omega"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0505","series-title":"Microbiota-Gut-Brain Axis and CNS Disorders","first-page":"19","article-title":"Chapter 2 - role of microbiota-gut-brain axis in Alzheimer's disease and possible interventions","author":"Pujari","year":"2025"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0510","first-page":"37","article-title":"Tangled connection of gut microbiome and Alzheimer's disease","author":"Pujari","year":"2025","journal-title":"Neuro-Nutraceuticals and Drug Discovery and Delivery in Alzheimer's Disease"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0515","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3233\/JAD-160612","article-title":"Amyloid-Beta and Phosphorylated tau accumulations cause abnormalities at synapses of Alzheimer\u2019s disease neurons","volume":"57","author":"Rajmohan","year":"2017","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0520","doi-asserted-by":"crossref","DOI":"10.1007\/s13205-022-03123-4","article-title":"Hippocampus and its involvement in Alzheimer\u2019s disease: a review","volume":"12","author":"Rao","year":"2022","journal-title":"3 Biotech"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0525","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/9982954","article-title":"Inflammation and Alzheimer\u2019s disease: mechanisms and therapeutic implications by natural products","volume":"2021","author":"Rather","year":"2021","journal-title":"Mediators Inflamm."},{"issue":"21","key":"10.1016\/j.pnpbp.2026.111660_bb0530","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232112841","article-title":"Phosphorylated tau in Alzheimer\u2019s disease and other Tauopathies","volume":"23","author":"Rawat","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"s1","key":"10.1016\/j.pnpbp.2026.111660_bb0535","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-191280","article-title":"Lifestyle and risk factors of dementia in rural West Texas","volume":"72","author":"Reddy","year":"2019","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"8","key":"10.1016\/j.pnpbp.2026.111660_bb0540","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1093\/hmg\/ddx052","article-title":"Mitochondria-targeted small molecule SS31: a potential candidate for the treatment of Alzheimer\u2019s disease","volume":"26","author":"Reddy","year":"2017","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0545","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/9259646","article-title":"Biologics for targeting inflammatory cytokines, clinical uses, and limitations","volume":"2016","author":"Rider","year":"2016","journal-title":"Int J Cell Biol"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0550","doi-asserted-by":"crossref","DOI":"10.1093\/braincomms\/fcaa109","article-title":"Anti-inflammatories in Alzheimer\u2019s disease-potential therapy or spurious correlate?","volume":"2","author":"Rivers-Auty","year":"2020","journal-title":"Brain Commun"},{"issue":"48","key":"10.1016\/j.pnpbp.2026.111660_bb0555","doi-asserted-by":"crossref","first-page":"11061","DOI":"10.1523\/JNEUROSCI.3034-05.2005","article-title":"Soluble beta-amyloid1-40 induces NMDA-dependent degradation of postsynaptic density-95 at glutamatergic synapses","volume":"25","author":"Roselli","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0560","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.3389\/fmed.2024.1474043","article-title":"Alzheimer\u2019s disease: a comprehensive review of epidemiology, risk factors, symptoms diagnosis, management, caregiving, advanced treatments and associated challenges [review]","volume":"Volume 11","author":"Safiri","year":"2024","journal-title":"Front. Med."},{"issue":"6","key":"10.1016\/j.pnpbp.2026.111660_bb0565","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2217\/nmt-2020-0033","article-title":"Riluzole for the treatment of amyotrophic lateral sclerosis","volume":"10","author":"Saitoh","year":"2020","journal-title":"Neurodegener Dis Manag"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111660_bb0570","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1111\/ejn.12183","article-title":"Impact of aging brain circuits on cognition","volume":"37","author":"Samson","year":"2013","journal-title":"Eur. J. Neurosci."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0575","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.jalz.2017.09.008","article-title":"Amyloid \u03b2 synaptotoxicity is Wnt-PCP dependent and blocked by fasudil","volume":"14","author":"Sellers","year":"2018","journal-title":"Alzheimers Dement."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0580","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10040742","article-title":"Addressing blood-brain barrier impairment in Alzheimer\u2019s disease","volume":"10","author":"Sharma","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0585","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102483","article-title":"Deciphering the role of miRNAs in Alzheimer\u2019s disease: predictive targeting and pathway modulation \u2013 A systematic review","volume":"101","author":"Sharma","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0590","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2024.1408462","article-title":"Molecular mechanisms and therapeutic potential of lithium in Alzheimer's disease: repurposing an old class of drugs","volume":"15","author":"Shen","year":"2024","journal-title":"Front. Pharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111660_bb0595","doi-asserted-by":"crossref","first-page":"668","DOI":"10.2174\/1871527317666180619162649","article-title":"Dantrolene : from malignant hyperthermia to Alzheimer's disease","volume":"18","author":"Shi","year":"2019","journal-title":"CNS Neurol. Disord. Drug Targets"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0600","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2022.870517","article-title":"Impact of anti-amyloid-\u03b2 monoclonal antibodies on the pathology and clinical profile of Alzheimer's disease: A focus on Aducanumab and Lecanemab","volume":"14","author":"Shi","year":"2022","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0605","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2024.102321","article-title":"Advances in gene therapy approaches targeting neuro-inflammation in neurodegenerative diseases","volume":"98","author":"Singh","year":"2024","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0610","doi-asserted-by":"crossref","DOI":"10.1007\/s12013-025-01944-7","article-title":"Therapeutic potential of Phytocompounds Gentisic acid and alpha Resorcylic acid against Alzheimer's disease: A network pharmacology, in silico, and in vitro approach","author":"Soni","year":"2025","journal-title":"Cell Biochem. Biophys."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0615","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2025.177520","article-title":"Exploring Alzheimer's disease treatment: established therapies and novel strategies for future care","volume":"998","author":"Soni","year":"2025","journal-title":"Eur. J. Pharmacol."},{"issue":"9","key":"10.1016\/j.pnpbp.2026.111660_bb0620","doi-asserted-by":"crossref","first-page":"5476","DOI":"10.1111\/ejn.15685","article-title":"A multi-hit hypothesis for an APOE4-dependent pathophysiological state","volume":"56","author":"Steele","year":"2022","journal-title":"Eur. J. Neurosci."},{"issue":"5","key":"10.1016\/j.pnpbp.2026.111660_bb0625","article-title":"Protein oxidation in aging and Alzheimer\u2019s disease brain","volume":"13","author":"Sultana","year":"2024","journal-title":"Antioxidants (Basel)"},{"key":"10.1016\/j.pnpbp.2026.111660_bb0630","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3389\/fphar.2015.00221","article-title":"\u0392-Amyloid: the key peptide in the pathogenesis of Alzheimer\u2019s disease","volume":"6","author":"Sun","year":"2015","journal-title":"Front. Pharmacol."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0635","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1007\/s40120-022-00338-8","article-title":"Alzheimer\u2019s disease: epidemiology and clinical progression","volume":"11","author":"Tahami Monfared","year":"2022","journal-title":"Neurol Ther"},{"issue":"21","key":"10.1016\/j.pnpbp.2026.111660_bb0640","doi-asserted-by":"crossref","first-page":"14742","DOI":"10.1039\/D4RA01536C","article-title":"Pregnenolone derivatives for the treatment of Alzheimer's disease: synthesis, and in vitro inhibition of amyloid \u03b2(1-42) peptide aggregation, acetylcholinesterase and carbonic anhydrase-II","volume":"14","author":"Tahir","year":"2024","journal-title":"RSC Adv."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0645","doi-asserted-by":"crossref","DOI":"10.3390\/cells15010078","article-title":"Neurogenesis and Neuroinflammation in dialogue: mapping gaps, modulating microglia, rewiring aging","volume":"15","author":"Tanaka","year":"2026","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0650","doi-asserted-by":"crossref","DOI":"10.1111\/acel.12731","article-title":"Treatment with the mitochondrial-targeted antioxidant peptide SS-31 rescues neurovascular coupling responses and cerebrovascular endothelial function and improves cognition in aged mice","volume":"17","author":"Tarantini","year":"2018","journal-title":"Aging Cell"},{"issue":"11","key":"10.1016\/j.pnpbp.2026.111660_bb0655","doi-asserted-by":"crossref","first-page":"5938","DOI":"10.3390\/ijms23115938","article-title":"An overview of oxidative stress, Neuroinflammation, and neurodegenerative diseases","volume":"23","author":"Teleanu","year":"2022","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0660","doi-asserted-by":"crossref","first-page":"721","DOI":"10.3233\/JAD-2010-1271","article-title":"Tau phosphorylated at tyrosine 394 is found in Alzheimer\u2019s disease tangles and can be a product of the Abl-related kinase, Arg","volume":"19","author":"Tremblay","year":"2010","journal-title":"J. Alzheimers Dis."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0665","doi-asserted-by":"crossref","first-page":"944","DOI":"10.3390\/ijms26030944","article-title":"Elamipretide: A review of its structure, mechanism of action, and therapeutic potential","volume":"26","author":"Tung","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"4, Part A","key":"10.1016\/j.pnpbp.2026.111660_bb0670","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.bbadis.2018.01.023","article-title":"Amyloid-\u03b2 oligomers synaptotoxicity: the emerging role of EphA4\/c-Abl signaling in Alzheimer\u2019s disease","volume":"1864","author":"Vargas","year":"2018","journal-title":"Biochim. Biophys. Acta (BBA) - Mol. Basis Dis."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0675","doi-asserted-by":"crossref","first-page":"317","DOI":"10.3233\/JAD-230151","article-title":"Inhibition of pro-inflammatory microglia with minocycline improves cognitive and sleep-wake dysfunction under respiratory stress in a sporadic model for Alzheimer\u2019s disease","volume":"95","author":"Vicente","year":"2023","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"12","key":"10.1016\/j.pnpbp.2026.111660_bb0680","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10123000","article-title":"Cannabinoid CB2 receptors in neurodegenerative proteinopathies: new insights and therapeutic potential","volume":"10","author":"Vuic","year":"2022","journal-title":"Biomedicines"},{"issue":"10","key":"10.1016\/j.pnpbp.2026.111660_bb0685","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/s41422-019-0216-x","article-title":"Sodium oligomannate therapeutically remodels gut microbiota and suppresses gut bacterial amino acids-shaped neuroinflammation to inhibit Alzheimer's disease progression","volume":"29","author":"Wang","year":"2019","journal-title":"Cell Res."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0690","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s13024-020-00376-6","article-title":"Mitochondria dysfunction in the pathogenesis of Alzheimer's disease: recent advances","volume":"15","author":"Wang","year":"2020","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0695","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1161850","article-title":"Revisiting the neuroinflammation hypothesis in Alzheimer\u2019s disease: a focus on the druggability of current targets","volume":"14","author":"Wong-Guerra","year":"2023","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.pnpbp.2026.111660_bb0700","doi-asserted-by":"crossref","first-page":"785","DOI":"10.3233\/JAD-230199","article-title":"Microglia-astrocyte communication in Alzheimer\u2019s disease","volume":"95","author":"Wu","year":"2023","journal-title":"J. Alzheimer\u2019s Dis"},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0705","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41392-025-02253-4","article-title":"Mitochondria in oxidative stress, inflammation and aging: from mechanisms to therapeutic advances","volume":"10","author":"Xu","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"issue":"7","key":"10.1016\/j.pnpbp.2026.111660_bb0710","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0224952","article-title":"Screening of tau protein kinase inhibitors in a tauopathy-relevant cell-based model of tau hyperphosphorylation and oligomerization","volume":"15","author":"Yadikar","year":"2020","journal-title":"PloS One"},{"issue":"50","key":"10.1016\/j.pnpbp.2026.111660_bb0715","doi-asserted-by":"crossref","first-page":"34554","DOI":"10.1074\/jbc.M801487200","article-title":"The low density lipoprotein receptor-related protein 1 mediates uptake of amyloid beta peptides in an in vitro model of the blood-brain barrier cells","volume":"283","author":"Yamada","year":"2008","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0720","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2021.104988","article-title":"Role of the endolysosomal pathway and exosome release in tau propagation","volume":"145","author":"Yan","year":"2021","journal-title":"Neurochem. Int."},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0725","doi-asserted-by":"crossref","DOI":"10.3390\/cells14040276","article-title":"Mitochondrial dysfunction in neurodegenerative diseases","volume":"14","author":"Yang","year":"2025","journal-title":"Cells"},{"issue":"2","key":"10.1016\/j.pnpbp.2026.111660_bb0730","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.cell.2020.11.049","article-title":"Structural basis of \u03b3-secretase inhibition and modulation by small molecule drugs","volume":"184","author":"Yang","year":"2021","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.pnpbp.2026.111660_bb0735","doi-asserted-by":"crossref","first-page":"3841","DOI":"10.3390\/ijms24043841","article-title":"Neurotransmitters in prevention and treatment of Alzheimer's disease","volume":"24","author":"Yang","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0740","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s10020-024-00808-9","article-title":"Endoplasmic reticulum stress and therapeutic strategies in metabolic, neurodegenerative diseases and cancer","volume":"30","author":"Yuan","year":"2024","journal-title":"Mol. Med."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0745","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.nbd.2016.07.007","article-title":"The blood-brain barrier in Alzheimer's disease","volume":"107","author":"Zenaro","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0750","article-title":"Role of a\u03b2 in Alzheimer's-related synaptic dysfunction","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Cell Dev. Biol."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0755","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41392-023-01484-7","article-title":"Amyloid \u03b2-based therapy for Alzheimer's disease: challenges, successes and future","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0760","doi-asserted-by":"crossref","DOI":"10.3389\/fnmol.2020.00137","article-title":"Targeting Amyloidogenic processing of APP in Alzheimer's disease [review]","volume":"13","author":"Zhao","year":"2020","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.pnpbp.2026.111660_bb0765","article-title":"Targeting aging hallmarks in brain health within the framework of preventive medicine: mechanistic insights into naringenin's role in longevity, synaptic function, and cellular homeostasis","volume":"12","author":"Zhi","year":"2025","journal-title":"Front. Nutr."},{"issue":"1","key":"10.1016\/j.pnpbp.2026.111660_bb0770","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41392-020-00428-9","article-title":"Ferroptosis: mechanisms and links with diseases","volume":"6","author":"Yan","year":"2021","journal-title":"Signal Transduct. Target. Ther."}],"container-title":["Progress in Neuro-Psychopharmacology and Biological Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278584626000564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:30:41Z","timestamp":1793950241000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278584626000564"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":155,"alternative-id":["S0278584626000564"],"URL":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111660","relation":{},"ISSN":["0278-5846"],"issn-type":[{"value":"0278-5846","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elucidating the molecular targets in Alzheimer's disease: Advances and therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Progress in Neuro-Psychopharmacology and Biological Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pnpbp.2026.111660","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111660"}}